Literature DB >> 6608388

Electromechanical effects of bepridil on rabbit isolated hearts.

T Anno, T Furuta, M Itoh, I Kodama, J Toyama, K Yamada.   

Abstract

Electromechanical effects of a new antianginal agent, bepridil, on Langendorff-perfused rabbit hearts were compared with those of verapamil and lidocaine. Bepridil at concentrations above 2 X 10(-7)M caused a dose-related decrease in heart rate (HR), a prolongation of the atrio-His bundle conduction time (A-H interval) and a prolongation of the functional refractory period (FRP) of the atrioventricular (A-V) node. Similar changes in HR, A-H interval and the FRP of the A-V node were observed with verapamil at concentrations above 2 X 10(-8)M. Lidocaine at above 4 X 10(-5)M prolonged slightly the A-H interval and the FRP of the A-V node but did not decrease the HR. Bepridil at concentrations above 10(-6)M prolonged both the His bundle-ventricular conduction time (H-V interval) and the effective refractory period (ERP) of ventricular muscles. Similar changes in the H-V interval and in the ERP of ventricular muscles were observed with lidocaine at above 10(-5)M. Verapamil ranging between 5 X 10(-8)M and 8 X 10(-7)M had no effect on the H-V interval and appreciably shortened the ERP of ventricular muscles. Bepridil at concentrations above 2 X 10(-6)M reduced the developed tension as did verapamil at above 10(-7)M. On a molar basis, the depressant effect of bepridil on HR and the A-V nodal conduction, which may reflect inhibitory action on the slow channels, was less than one tenth that of verapamil. Bepridil was more potent than lidocaine in prolonging the H-V interval and the ERP of ventricular muscles indicating a possible inhibition of the fast sodium channels. Both of these electrophysiological effects of bepridil may afford significant bases for the antiarrhythmic action of the drug.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6608388      PMCID: PMC1986954          DOI: 10.1111/j.1476-5381.1984.tb10741.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  18 in total

Review 1.  Electrophysiology and pharmacology of cardiac arrhythmias. V. Cardiac antiarrhythmic effects of lidocaine.

Authors:  M R Rosen; B F Hoffman; A L Wit
Journal:  Am Heart J       Date:  1975-04       Impact factor: 4.749

2.  Inotropic and electrophysiological actions of verapamil and D 600 in mammalian myocardium. III. Effects of the optical isomers on transmembrane action potentials.

Authors:  R Bayer; D Kalusche; R Kaufmann; R Mannhold
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1975       Impact factor: 3.000

3.  The role of local disparity in conduction and recovery time on ventricular vulnerability to fibrillation.

Authors:  W Merx; M S Yoon; J Han
Journal:  Am Heart J       Date:  1977-11       Impact factor: 4.749

Review 4.  Comparative physiology of the cardiac pacemaker mechanism.

Authors:  H Irisawa
Journal:  Physiol Rev       Date:  1978-04       Impact factor: 37.312

5.  Effects of verapamil on canine Purkinje fibres and ventricular muscle fibres with particular reference to the alternation of action potential duration after a sudden increase in driving rate.

Authors:  Y Hirata; I Kodama; N Iwamura; T Shimizu; J Toyama; K Yamada
Journal:  Cardiovasc Res       Date:  1979-01       Impact factor: 10.787

6.  Effect of verapamil on the sinoatrial and atrioventricular nodes of the rabbit and the mechanism by which it arrests reentrant atrioventricular nodal tachycardia.

Authors:  A L Wit; P F Cranefield
Journal:  Circ Res       Date:  1974-09       Impact factor: 17.367

7.  Effects of verapamil on electrophysiologic properties of canine cardiac Purkinje fibers.

Authors:  M R Rosen; J P Ilvento; H Gelband; C Merker
Journal:  J Pharmacol Exp Ther       Date:  1974-05       Impact factor: 4.030

Review 8.  Electrophysiology and pharmacology of cardiac arrhythmias. VI. Cardiac effects of verapamil.

Authors:  M R Rosen; A L Wit; B F Hoffman
Journal:  Am Heart J       Date:  1975-05       Impact factor: 4.749

Review 9.  Comparative mechanisms of action of antiarrhythmic drugs.

Authors:  B N Singh; O Hauswirth
Journal:  Am Heart J       Date:  1974-03       Impact factor: 4.749

10.  Cardiovascular pharmacology of bepridil (1[3 isobutoxy 2 (benzylphenyl) amino] propyl pyrrolidine hydrochloride) a new potential anti-anginal compound.

Authors:  D Cosnier; P Duchenne-Marullaz; G Rispat; G Streichenberger
Journal:  Arch Int Pharmacodyn Ther       Date:  1977-01
View more
  3 in total

1.  Bepridil differentially inhibits two delayed rectifier K(+) currents, I(Kr) and I(Ks), in guinea-pig ventricular myocytes.

Authors:  J C Wang; T Kiyosue; K Kiriyama; M Arita
Journal:  Br J Pharmacol       Date:  1999-12       Impact factor: 8.739

2.  Effects of bepridil and lidocaine on the intraventricular conduction in acutely ischaemic and infarcted canine myocardium.

Authors:  H Hashimoto; N Satoh; M Nakashima
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1990-12       Impact factor: 3.000

3.  Interactions between a "calcium channel agonist", Bay K 8644, and calcium antagonists differentiate calcium antagonist subgroups in K+-depolarized smooth muscle.

Authors:  M Spedding; C Berg
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1984-11       Impact factor: 3.000

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.